44 related articles for article (PubMed ID: 2627627)
1. Molecular biology to check patients treated for CML.
Saglio G; Zaccaria A; Tassinari A; Rosti G; Lo Coco F; Diverio D; Rege Cambrin G; Scaravaglio P; Rosso C; Guerrasio A
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():98-100. PubMed ID: 2627627
[No Abstract] [Full Text] [Related]
2. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
Furukawa Y; Ju SL; Cho HL; Tatsumi N
Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
[TBL] [Abstract][Full Text] [Related]
3. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
4. [The molecular biology diagnosis of neoplastic blood diseases].
Teleheiev HD; Dybkov MV; Bozhko MV; Tretiak NM; Maliuta SS
Tsitol Genet; 1998; 32(1):71-8. PubMed ID: 9695255
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
6. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.
Burmeister T; Reinhardt R
Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051
[TBL] [Abstract][Full Text] [Related]
7. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
Nakata Y
Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
[TBL] [Abstract][Full Text] [Related]
8. [CML with mu-BCR/ABL mRNA: clinical characteristics of our three cases and 26 reported cases].
Ito T
Rinsho Ketsueki; 2003 Apr; 44(4):234-41. PubMed ID: 12784656
[No Abstract] [Full Text] [Related]
9. Detection and direct sequence identification of BCR-ABL mRNA in Ph+ chronic myeloid leukemia.
Sooknanan R; Malek L; Wang XH; Siebert T; Keating A
Exp Hematol; 1993 Dec; 21(13):1719-24. PubMed ID: 8243571
[TBL] [Abstract][Full Text] [Related]
10. Differential display analysis of mRNAs in chronic myelogenous leukaemia.
el-Awady MK; Abdalla NM; Salem AM; Samir S; Nour AM
East Mediterr Health J; 2001; 7(4-5):707-15. PubMed ID: 15332769
[TBL] [Abstract][Full Text] [Related]
11. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases.
Martínez-López J; Ayala R; Albizua Q
Haematologica; 2002 Aug; 87(8):ELT35. PubMed ID: 12161380
[No Abstract] [Full Text] [Related]
12. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
13. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia.
Wright L; Wilson SB; Milliken S; Biggs J; Kearney P
Exp Hematol; 1993 Dec; 21(13):1714-8. PubMed ID: 8243570
[TBL] [Abstract][Full Text] [Related]
14. [Use of polymerase chain reaction for determining bcr/abl mRNA in human chronic myeloleukemia].
Dominskiĭ DA; Pokrovskaia ES; Babushkina EA; Turkina AG; Grineva NI
Genetika; 1994 Dec; 30(12):1636-9. PubMed ID: 7534246
[TBL] [Abstract][Full Text] [Related]
15. Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia.
Romero P; Beran M; Shtalrid M; Andersson B; Talpaz M; Blick M
Oncogene; 1989 Jan; 4(1):93-8. PubMed ID: 2915904
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme mediated therapy for chronic myelogenous leukemia.
Leopold LH; Shore SK; Newkirk T; Mangan K; Reddy EP
Prog Clin Biol Res; 1994; 389():175-82. PubMed ID: 7700900
[No Abstract] [Full Text] [Related]
17. A nested RT-PCR assay to detect BCR/abl.
Wasserman LM
Methods Mol Med; 2004; 97():181-9. PubMed ID: 15064493
[No Abstract] [Full Text] [Related]
18. Analysis of BCR/ABL transcripts in chronic myeloid patients by nested PCR using an immunoassay-like detection format.
Barbu V; Alpha-Bazin B; Pepin D; Morand-Joubert L; Chypre C; Bereziat G
Mol Cell Probes; 1994 Jun; 8(3):251-6. PubMed ID: 7969201
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
Goh HG; Hwang JY; Kim SH; Lee YH; Kim YL; Kim DW
Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
[TBL] [Abstract][Full Text] [Related]
20. Quantitative molecular methods to monitor the response of CML patients to interferon-alpha.
Hochhaus A; Lin F; Reiter A; Skladny H; Hehlmann R; Goldman JM; Cross NC
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S41-4. PubMed ID: 8769700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]